A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  • Briggs, Peter (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/19 → 31/10/24

Keywords

  • clinical trial
  • phase 3 study
  • lung cancer
  • treatment efficacy